Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Zimmer Biomet Holdings, Inc.(ZBH) | 1,925,000 | 2,500,000 | +575,000 | $208.9K | $269.9K | 10.48% | +$61.0K |
| Medtronic plcSHS(MDT) | 2,250,000 | 2,750,000 | +500,000 | $177.1K | $247.6K | 9.62% | +$70.5K |
| Baxter Intl Inc | 5,500,000 | 6,500,000 | +1,000,000 | $184.0K | $246.8K | 9.59% | +$62.8K |
| Viatris Inc.(VTRS) | 15,000,000 | 15,000,000 | 0 | $159.4K | $174.2K | 6.76% | +$14.7K |
| Globus Medical, Inc.CL A(GMED) | 2,500,000 | 2,150,000 | -350,000 | $171.2K | $153.8K | 5.97% | -$17.4K |
| PTC Therapeutics, Inc.(PTCT) | 3,500,000 | 3,500,000 | 0 | $107.0K | $129.8K | 5.04% | +$22.8K |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 1,150,000 | 1,150,000 | 0 | $122.7K | $128.1K | 4.98% | +$5.4K |
| GSK plcADR(GSK) | 2,675,000 | 3,000,000 | +325,000 | $103.0K | $122.6K | 4.76% | +$19.7K |
| Myriad Genetics, Inc.(MYGN) | 5,500,000 | 3,950,000 | -1,550,000 | $134.5K | $108.2K | 4.20% | -$26.3K |
| Ascendis Pharma A/SADR(ASND) | 0 | 700,000 | +700,000 | $0 | $104.5K | 4.06% | +$104.5K |
| Sarepta Therapeutics, Inc.(SRPT) | 150,000 | 775,000 | +625,000 | $23.7K | $96.8K | 3.76% | +$73.1K |
| Brookdale Senior Living Inc.(BKD) | 15,500,000 | 13,935,000 | -1,565,000 | $105.9K | $94.6K | 3.67% | -$11.2K |
| CVS Health Corporation(CVS) | 1,500,000 | 1,500,000 | 0 | $88.6K | $94.3K | 3.66% | +$5.7K |
| Select Med Hldgs Corp | 2,550,000 | 2,125,000 | -425,000 | $89.4K | $74.1K | 2.88% | -$15.3K |
| Qiagen N.V.SHS NEW(QGEN) | 1,500,000 | 1,500,000 | 0 | $61.6K | $68.4K | 2.65% | +$6.7K |
| Humana Inc.(HUM) | 400,000 | 200,000 | -200,000 | $149.5K | $63.3K | 2.46% | -$86.1K |
| Denali Therapeutics Inc.(DNLI) | 2,000,000 | 2,000,000 | 0 | $46.4K | $58.3K | 2.26% | +$11.8K |
| Concentra Group Holdings Parent, Inc.(CON) | 0 | 1,975,000 | +1,975,000 | $0 | $44.2K | 1.72% | +$44.2K |
| Zimvie Inc | 3,250,000 | 2,725,000 | -525,000 | $59.3K | $43.2K | 1.68% | -$16.1K |
| Medpace Holdings, Inc.(MEDP) | 0 | 125,000 | +125,000 | $0 | $41.7K | 1.62% | +$41.7K |
| Evolent Health, Inc.CL A(EVH) | 625,000 | 1,400,000 | +775,000 | $11.9K | $39.6K | 1.54% | +$27.6K |
| Universal Health Services, Inc.CL B(UHS) | 950,000 | 125,000 | -825,000 | $175.7K | $28.6K | 1.11% | -$147.1K |
| Brookdale Senior Living Inc.UNIT 11 15 2025(BKD) | 250,000 | 250,000 | 0 | $23.2K | $23.1K | 0.90% | -$159 |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 355,000 | 441,000 | +86,000 | $15.6K | $22.2K | 0.86% | +$6.6K |
| Herbalife Ltd.(HLF) | 3,000,000 | 3,000,000 | 0 | $31.2K | $21.6K | 0.84% | -$9.6K |
| Bicycle Therapeutics PlcADS | 915,000 | 915,000 | 0 | $18.5K | $20.7K | 0.80% | +$2.2K |
| Inogen, Inc.(INGN) | 2,000,000 | 2,000,000 | 0 | $16.3K | $19.4K | 0.75% | +$3.1K |
| OraSure Technologies, Inc.(OSUR) | 4,250,000 | 4,250,000 | 0 | $18.1K | $18.1K | 0.70% | +$43 |
| Theravance Biopharma Inc | 1,000,000 | 1,000,000 | 0 | $8.5K | $8.1K | 0.31% | -$420 |
| Alkermes plcSHS(ALKS) | 0 | 200,000 | +200,000 | $0 | $5.6K | 0.22% | +$5.6K |
| SkinHealth Systems Inc.CL A(SKIN) | 3,500,000 | 1,500,000 | -2,000,000 | $6.7K | $2.2K | 0.08% | -$4.6K |
| Genmab A/SADS(GMAB) | 50,000 | 50,000 | 0 | $1.3K | $1.2K | 0.05% | -$38 |
| Anaptysbio Inc | 500,000 | 0 | -500,000 | $12.5K | $0 | — | -$12.5K |
| argenx SEADR(ARGX) | 72,000 | 0 | -72,000 | $31.0K | $0 | — | -$31.0K |
| BioMarin Pharmaceutical Inc.(BMRN) | 1,100,000 | 0 | -1,100,000 | $90.6K | $0 | — | -$90.6K |
| Curevac N V | 550,000 | 0 | -550,000 | $1.9K | $0 | — | -$1.9K |
| Perrigo Company plcSHS(PRGO) | 1,520,000 | 0 | -1,520,000 | $39.0K | $0 | — | -$39.0K |
| Replimune Group, Inc.(REPL) | 1,350,000 | 0 | -1,350,000 | $12.2K | $0 | — | -$12.2K |
| Walgreens Boots Alliance Inc | 7,000,000 | 0 | -7,000,000 | $84.7K | $0 | — | -$84.7K |